Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.48 |
| ▸ | CES1 | P23141 | 7/20 | 0.48 |
| ▸ | CES2 | O00748 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30312755 | 1.00 | FAAH (0.48) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL30312783 | 1.00 | FAAH (0.48) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL30361058 | 1.00 | FAAH (0.48) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL9436013 | 0.81 | FAAH (0.44) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL30525458 | 0.81 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL2875479 | 0.78 | FAAH (0.52) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL9472467 | 0.78 | FAAH (0.52) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL8088152 | 0.77 | FAAH (0.47) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL8345161 | 0.76 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL136430 | 0.76 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4603481-A1 | PREPARATION AND USE OF CATIONIC LIPID MATERIAL | Nanjing Geneleap Biotechnology Co., Ltd. (CN) | 2025-08-20 | — | — | EP | claimed |
| CN-120078734-A | Lipid nanoparticle for delivering nucleic acid and preparation method and application thereof | 康希诺(上海)生物研发有限公司 | 2025-06-03 | — | — | CN | claimed |
| WO-2024131717-A1 | PREPARATION AND USE OF CATIONIC LIPID MATERIAL | 南京吉迈生物技术有限公司 | 2024-06-27 | — | — | WO | claimed |
| CN-118221556-A | Ionizable cationic lipid material, and preparation method and application thereof | 南京吉迈生物技术有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118108813-A | S protein mutant of 2019-nCoV Omicron strain and genetically engineered mRNA thereof | 北京启辰生生物科技有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-118078752-A | Lipid composition for gene editing agent delivery and uses thereof | 北京启辰生生物科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-118064466-A | Polynucleotide for coding recombinant interleukin 12 and application thereof | 北京启辰生生物科技有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-118059059-A | Freeze-dried preparation of lipid nano particles | 北京启辰生生物科技有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-118059222-A | Lyophilized preparation of mRNA lipid nanoparticle of 2019-nCoV S protein | 北京启辰生生物科技有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-118021754-A | Needleless injector and lipid nanoparticle delivery system | 北京启辰生生物科技有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117624381-A | Therapeutic HPV mRNA vaccine and application thereof | 启辰生生物科技(珠海)有限公司 | 2024-03-01 | — | — | CN | claimed |
| WO-2023056872-A1 | LIPID NANOPARTICLE COMPOSITION AND DRUG DELIVERY SYSTEM PREPARED THEREBY | 北京启辰生生物科技有限公司 | 2023-04-13 | — | — | WO | claimed |
| EP-4603481-A1 | PREPARATION AND USE OF CATIONIC LIPID MATERIAL | Nanjing Geneleap Biotechnology Co., Ltd. (CN) | 2025-08-20 | — | — | EP | disclosed |
| CN-120081892-A | Ionizable cationic lipid compound and application thereof | 康希诺(上海)生物研发有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-120078734-A | Lipid nanoparticle for delivering nucleic acid and preparation method and application thereof | 康希诺(上海)生物研发有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-120081891-A | Ionizable cationic lipid compound and application thereof | 康希诺(上海)生物研发有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-117487857-A | Modified nucleotide combination for enhancing antigen Survivin and/or human EGF receptor 2 and application thereof | 北京启辰生生物科技有限公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-117229371-A | Novel S protein mutant of coronavirus variant strain, genetically engineered mRNA thereof and vaccine composition | 北京启辰生生物科技有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-114344278-B | Nucleic acid delivery vectors and uses thereof | 南京吉迈生物技术有限公司 | 2023-06-06 | — | — | CN | disclosed |
| WO-2023056872-A1 | LIPID NANOPARTICLE COMPOSITION AND DRUG DELIVERY SYSTEM PREPARED THEREBY | 北京启辰生生物科技有限公司 | 2023-04-13 | — | — | WO | disclosed |